BAD ELISA Kit

Produktnummer ABIN2945561

Produktdetails BAD ELISA Kit

Target: BAD (BCL2-Associated Agonist of Cell Death (BAD))

Reaktivität: Human

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 125 pg/mL - 8000 pg/mL

Untere Nachweisgrenze: 125 pg/mL

Applikation: ELISA

Verwendungszweck: Human Bcl2 Associated Death Promoter ELISA Kit is an ELISA Kit against Bcl2 Associated Death Promoter.

Proben: Plasma, Serum

Analytische Methode: Quantitative

Sensitivität: 75 pg/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Details zu BAD

Target: BAD (BCL2-Associated Agonist of Cell Death (BAD))

Andere Bezeichnung: Bcl2 Antagonist of Cell Death (BAD Produkte)

Synonyme: bad ELISA Kit, fa01b12 ELISA Kit, wu:fa01b12 ELISA Kit, wu:fa96d04 ELISA Kit, BAD ELISA Kit, BBC2 ELISA Kit, BCL2L8 ELISA Kit, AI325008 ELISA Kit, Bbc2 ELISA Kit, BCL2-associated agonist of cell death b ELISA Kit, BCL2 associated agonist of cell death ELISA Kit, BCL2-associated agonist of cell death ELISA Kit, badb ELISA Kit, BAD ELISA Kit, Bad ELISA Kit

Pathways: MAPK Signalweg, PI3K-Akt Signalweg, RTK Signalweg, Apoptose, Fc-epsilon Rezeptor Signalübertragung, Positive Regulation of Peptide Hormone Secretion, Carbohydrate Homeostasis, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Hepatitis C, CXCR4-mediated Signaling Events